- PLN3.19bn
- PLN4.07bn
- PLN13.64bn
Brief: Neuca Says Poland's Anti-Monopoly Office Starts Proceedings Against Company
Brief: Neuca Announces Offer To Buy Up To 32,624 Own Shares At 890 Zlotys Each
Brief: Neuca Unit Signs Investment Deal On Acquisition Of 100% Stake In Exom Group
Brief: Neuca Q2 Net Profit Up At 35.3 Mln Zlotys
Brief: Neuca Signs Settlement With Barbara Sobczyk And Rafal Sobczyk
Brief: Neuca Says Poland's Anti-Monopoly Office Approves Takeover Of Pomerania Investments By Company
Brief: Neuca AGM To Vote On FY 2020 Dividend Of 10 Zlotys/Shr
Brief: Neuca Updates Conditions Of Buyback Programme
Brief: Neuca Signs Prelim Deal To Buy Stake In Pomerania Investment
Brief: Neuca Q3 Net Profit Up At 44.7 Mln Zlotys
Brief: Neuca Price Under Buyback Up To 600 Zlotys/Shr
Brief: Neuca Launches Buyback Of Up To 5% Of Own Shares
Brief: Neuca AGM To Vote On 2019 Dividend Of 8.65 Zlotys/Shr
Brief: Neuca FY Net Profit Up At 117.7 Mln Zlotys
Brief: Neuca Raises Share Capital By 81,535 Zlotys To 4.6 Mln Zlotys
Brief: Neuca Plans To Merge With Its Wholly-Owned Unit Prosper
Brief: Neuca Q3 Net Profit Up At 28.0 Mln Zlotys
Brief: Neuca Resolves To Merge With Wholly-Owned ACP Pharma
Brief: Neuca Q2 Net Profit Up At 28.8 Mln Zlotys